Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
Haak HE, Beets GL, Peeters K, Nelemans PJ, Valentini V, Rödel C, Kuo L, Calvo FA, Garcia-Aguilar J, Glynne-Jones R, Pucciarelli S, Suarez J, Theodoropoulos G, Biondo S, Lambregts DMJ, Beets-Tan RGH, Maas M. Haak HE, et al. Among authors: rodel c. Br J Surg. 2021 Oct 23;108(10):1251-1258. doi: 10.1093/bjs/znab194. Br J Surg. 2021. PMID: 34240110 Free PMC article.
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic.
Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D. Marijnen CAM, et al. Among authors: rodel c. Radiother Oncol. 2020 Jul;148:213-215. doi: 10.1016/j.radonc.2020.03.039. Epub 2020 Apr 2. Radiother Oncol. 2020. PMID: 32342861 Free PMC article. No abstract available.
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial.
Hofheinz RD, Arnold D, Fokas E, Kaufmann M, Hothorn T, Folprecht G, Fietkau R, Hohenberger W, Ghadimi M, Liersch T, Grabenbauer GG, Sauer R, Rödel C, Graeven U; German Rectal Cancer Study Group. Hofheinz RD, et al. Among authors: rodel c. Ann Oncol. 2018 Aug 1;29(8):1793-1799. doi: 10.1093/annonc/mdy205. Ann Oncol. 2018. PMID: 29873684 Free article. Clinical Trial.
[Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J, Liersch T, Hess C, Becker H, Rödel C, Ghadimi BM. Gaedcke J, et al. Among authors: rodel c. Zentralbl Chir. 2011 Aug;136(4):334-42. doi: 10.1055/s-0031-1271581. Epub 2011 Aug 23. Zentralbl Chir. 2011. PMID: 21863511 Review. German.
Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences.
Balermpas P, Rödel F, Liberz R, Oppermann J, Wagenblast J, Ghanaati S, Harter PN, Mittelbronn M, Weiss C, Rödel C, Fokas E. Balermpas P, et al. Among authors: rodel c, rodel f. Br J Cancer. 2014 Oct 14;111(8):1509-18. doi: 10.1038/bjc.2014.446. Epub 2014 Aug 5. Br J Cancer. 2014. PMID: 25093488 Free PMC article.
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial.
Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, Ströbel P, Grabenbauer GG, Graeven U, Hofheinz RD, Köhne CH, Wittekind C, Sauer R, Kaufmann M, Hothorn T, Rödel C; German Rectal Cancer Study Group. Fokas E, et al. Among authors: rodel c. Ann Oncol. 2018 Jul 1;29(7):1521-1527. doi: 10.1093/annonc/mdy143. Ann Oncol. 2018. PMID: 29718095 Free article. Clinical Trial.
437 results